Blue Toe Syndrome

Known as: Blue Toe Syndrome [Disease/Finding], Syndrome, Blue Toe 
A condition that is caused by recurring atheroembolism in the lower extremities. It is characterized by cyanotic discoloration of the toes, usually… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
We present a patient with metastatic renal cell carcinoma treated with sunitinib, a multitargeted tyrosine kinase inhibitor. The… (More)
  • figure 1
Is this relevant?
2007
2007
Three patients, two women aged 66 and 43 years, respectively, and a man aged 76 years, presented with sudden, painful, blue areas… (More)
Is this relevant?
2005
2005
The authors report the case of a man with blue toe syndrome, who developed bilateral foot ischemia and underwent successful… (More)
  • table 1
  • table 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Cholesterol embolization syndrome is a systemic disease caused by distal showering of cholesterol crystals after… (More)
Is this relevant?
2003
2003
CONTEXT Blue toe syndrome is an unusual complication of acute pancreatitis. It is characterized by tissue ischemia secondary to… (More)
Is this relevant?
2002
2002
Blue toe syndrome is a manifestation of distal embolization associated with significant pain and risk of tissue loss. The… (More)
Is this relevant?
Review
1996
Review
1996
The blue toe syndrome is characterized by tissue ischemia secondary to cholesterol crystal or atherothrombotic embolization… (More)
Is this relevant?
Review
1992
Review
1992
The sudden development of cyanotic lesions on the feet may be a result of atheroembolic disease or a number of medical conditions… (More)
Is this relevant?
1989
1989
"Blue toe syndrome" refers to digital ischemia of the foot in the presence of palpable or Doppler audible pedal pulses. This… (More)
Is this relevant?
1988
1988
The spontaneous onset of a painful unilateral blue toe is usually caused by fibrinoplatelet microemboli arising from an upstream… (More)
Is this relevant?